Pharmacovigilance
First Job in Pharmacovigilance Program
Build a structured foundation across the core processes, regulations and responsibilities that shape pharmacovigilance work.
View programOur products
LEARNING AREA SUBSCRIPTION
Pharmacovigilance Subscription
Build your pharmacovigilance expertise with access to all courses and job-ready programs in this learning area. Get the latest course versions and new courses while your subscription is active.
33.25€/month
399.00€ billed annually
Access all 40 courses in Pharmacovigilance while your subscription is active.
- Latest course versions and new courses added to the learning area
- 5 job-ready programs included
- Course certificates and job-ready certificates
Everything included in your learning area
One subscription gives you the complete current learning area and keeps it up to date while your subscription is active.
JOB-READY PROGRAMS
Job-ready programs included
Choose any program in this learning area. Each program provides a focused 10-course curriculum and a job-ready certificate after completion.
Pharmacovigilance
Safety Data Management Specialist Program
Build practical knowledge of ICSR intake, coding, assessment, database processing, case documentation and safety-data workflows.
View program
Pharmacovigilance
Local Pharmacovigilance Specialist Program
Build structured knowledge of local pharmacovigilance operations, oversight, literature, agreements, PSMF, risk management and compliance activities.
View program
Pharmacovigilance
Pharmacovigilance Quality Specialist Program
Build structured knowledge of PV quality systems, process oversight, CAPA, audits, agreements and key pharmacovigilance control points.
View program
Pharmacovigilance
Pharmacovigilance Medical Writing Specialist Program
Build structured knowledge of case narratives, CCSI, PSURs, RMPs, risk-minimisation content and clinical-development safety reports.
View programCOURSE LIBRARY
Explore all courses in this learning area
Open a course to review its content, duration and learning outcomes. Every course below is included while your subscription is active.
Courses included in this subscription
-
Additional risk minimization measures
PharmacovigilanceRegulatory AffairsKarolina Smyl, Karolina Wawrzyniak
-
Assessment and Medical Evaluation of ICSR
PharmacovigilanceClinical TrialsAleksandra MalickaCertified by: -
-
-
-
Cosmetic product safety report and the role of the responsible person
PharmacovigilanceEwelina DrelichCertified by: -
-
Entering data into the Pharmacovigilance database system
PharmacovigilanceAleksandra MalickaCertified by: -
-
How to prepare case narrative and sender’s comment
PharmacovigilanceAleksandra MalickaCertified by: -
Introduction to audit and inspection report
PharmacovigilanceClinical TrialsAgnieszka SokółCertified by: -
Introduction to individual development plan
PharmacovigilanceClinical TrialsRegulatory AffairsMarcin Gołembski -
-
Introduction to organized post-marketing data collection systems
PharmacovigilanceClinical TrialsMonika Nowak, Marek HurdaCertified by: -
Introduction to Personal Data Protection in the pharmaceutical industry
PharmacovigilanceAnna Buczyńska-BorowyCertified by: -
Introduction to Pharmacovigilance Agreements and Service Provider Agreements
PharmacovigilanceKarolina Wawrzyniak, Anna KończakCertified by: -
Introduction to Quality Management System
PharmacovigilanceClinical TrialsAgnieszka SokółCertified by: -
-
Introduction to role of Qualified Person Responsible for Pharmacovigilance
PharmacovigilanceKatarzyna Baltyn, Anna KończakCertified by: -
Introduction to safety monitoring in clinical trials
PharmacovigilanceClinical TrialsMarek Hurda, Monika NowakCertified by: -
Introduction to the management of ICSRs
PharmacovigilanceClinical TrialsAleksandra MalickaCertified by: -
Introduction to Vaccine Safety Surveillance in EU
PharmacovigilanceAnastazja MarkowskaCertified by: -
Key updates on GVP Module XVI Risk minimisation measures (Rev 3) and Module XVI Addendum II
PharmacovigilanceKarolina Wawrzyniak -
Legal Regulations and Guidelines concerning Pharmacovigilance
PharmacovigilanceMonika TrojanCertified by: -
Management of Company Core Safety Information
PharmacovigilanceRegulatory AffairsJulita Wójcik, Anna Kończak -
Management of Periodic Safety Update Report
PharmacovigilanceKarolina Smyl, Karolina WawrzyniakCertified by: -
-
-
Medical Literature Monitoring based on journals review
PharmacovigilanceMarek Wykręt-BielskiCertified by: -
Medicines under additional monitoring, the black triangle
PharmacovigilanceRegulatory AffairsKatarzyna Kopacz-Zakrzewska -
Moving from hype to reality: how AI can really help tackle pharma challenges
PharmacovigilanceJulia Matuszewska, Jerzy Biernacki +2 -
Navigating EU CTR 536/2014 with transitioning from CTD
PharmacovigilanceClinical TrialsRegulatory AffairsKatarzyna Kopacz-Zakrzewska -
PRAC, CHMP, CMDh – the role and responsibilities that impact on the PV activities performed by MAH
PharmacovigilanceRegulatory AffairsAndrzej CzesławskiCertified by: -
Practical aspects of Personal Data Protection in Pharmacovigilance and Clinical Trials
PharmacovigilanceClinical TrialsAnna Buczyńska-BorowyCertified by: -
Practical aspects of the review of the medical literature
PharmacovigilanceMarek Wykręt-BielskiCertified by: -
PSUR single assessment procedure and informal Work-Sharing procedure for follow-up for PSUSA for NAPs
PharmacovigilanceAndrzej CzesławskiCertified by: -
-
The specifics of the Polish market in terms of the Risk Management Plan
PharmacovigilanceAndrzej CzesławskiCertified by: -
What is MedDRA and how is it used?
PharmacovigilanceRegulatory AffairsAleksandra MalickaCertified by: -
You may also like related courses…
-
-
Regulatory Affairs Subscription – Monthly
39.00€ / MonthLearning area: Regulatory AffairsSubscribe
Number of courses included: 36 -
Clinical Trials Subscription
399.00€ / YearLearning area: Clinical TrialsSubscribe
Number of courses included: 42
Courses included in this subscription
-
-
-
Navigating EU CTR 536/2014 with transitioning from CTD
PharmacovigilanceClinical TrialsRegulatory AffairsKatarzyna Kopacz-Zakrzewska -
-
Introduction to organized post-marketing data collection systems
PharmacovigilanceClinical TrialsMonika Nowak, Marek HurdaCertified by: -
What is MedDRA and how is it used?
PharmacovigilanceRegulatory AffairsAleksandra MalickaCertified by: -
Medicines under additional monitoring, the black triangle
PharmacovigilanceRegulatory AffairsKatarzyna Kopacz-Zakrzewska -
Practical aspects of the review of the medical literature
PharmacovigilanceMarek Wykręt-BielskiCertified by: -
Introduction to Personal Data Protection in the pharmaceutical industry
PharmacovigilanceAnna Buczyńska-BorowyCertified by: -
Practical aspects of Personal Data Protection in Pharmacovigilance and Clinical Trials
PharmacovigilanceClinical TrialsAnna Buczyńska-BorowyCertified by: -
Introduction to role of Qualified Person Responsible for Pharmacovigilance
PharmacovigilanceKatarzyna Baltyn, Anna KończakCertified by: -
Additional risk minimization measures
PharmacovigilanceRegulatory AffairsKarolina Smyl, Karolina Wawrzyniak -
-
Moving from hype to reality: how AI can really help tackle pharma challenges
PharmacovigilanceJulia Matuszewska, Jerzy Biernacki +2 -
Management of Periodic Safety Update Report
PharmacovigilanceKarolina Smyl, Karolina WawrzyniakCertified by: -
Assessment and Medical Evaluation of ICSR
PharmacovigilanceClinical TrialsAleksandra MalickaCertified by: -
Introduction to the management of ICSRs
PharmacovigilanceClinical TrialsAleksandra MalickaCertified by: -
PRAC, CHMP, CMDh – the role and responsibilities that impact on the PV activities performed by MAH
PharmacovigilanceRegulatory AffairsAndrzej CzesławskiCertified by: -
Introduction to individual development plan
PharmacovigilanceClinical TrialsRegulatory AffairsMarcin Gołembski -
PSUR single assessment procedure and informal Work-Sharing procedure for follow-up for PSUSA for NAPs
PharmacovigilanceAndrzej CzesławskiCertified by: -
Introduction to audit and inspection report
PharmacovigilanceClinical TrialsAgnieszka SokółCertified by: -
Entering data into the Pharmacovigilance database system
PharmacovigilanceAleksandra MalickaCertified by: -
Medical Literature Monitoring based on journals review
PharmacovigilanceMarek Wykręt-BielskiCertified by: -
-
-
Introduction to Quality Management System
PharmacovigilanceClinical TrialsAgnieszka SokółCertified by: -
-
The specifics of the Polish market in terms of the Risk Management Plan
PharmacovigilanceAndrzej CzesławskiCertified by: -
Management of Company Core Safety Information
PharmacovigilanceRegulatory AffairsJulita Wójcik, Anna Kończak -
-
Cosmetic product safety report and the role of the responsible person
PharmacovigilanceEwelina DrelichCertified by: -
Introduction to Vaccine Safety Surveillance in EU
PharmacovigilanceAnastazja MarkowskaCertified by: -
Key updates on GVP Module XVI Risk minimisation measures (Rev 3) and Module XVI Addendum II
PharmacovigilanceKarolina Wawrzyniak -
How to prepare case narrative and sender’s comment
PharmacovigilanceAleksandra MalickaCertified by: -
Introduction to Pharmacovigilance Agreements and Service Provider Agreements
PharmacovigilanceKarolina Wawrzyniak, Anna KończakCertified by: -
-
Legal Regulations and Guidelines concerning Pharmacovigilance
PharmacovigilanceMonika TrojanCertified by: -
-
-
Introduction to safety monitoring in clinical trials
PharmacovigilanceClinical TrialsMarek Hurda, Monika NowakCertified by: